In Phase A, participants will obtain different doses and schedules of oral ABBV-744 tablet to discover Secure dosing routine. More contributors is going to be enrolled within the identified monotherapy dosign regimen. In Section B, members will get oral ruxolitinib and ABBV-744 will probably be presented as "insert-on" therapy. In https://abbv-744andotherbrd4inhib24578.spintheblog.com/32459015/abbv-744-in-clinical-trials-for-non-small-cell-lung-cancer-nsclc-options